circRNA basic information
circBase ID: hsa_circ_0051908
Name: -
Synonym: -
Host Gene: -
Genomic location(hg19): chr19:50000450-50002944:+
Genomic location(hg38): chr19:49497193-49499687:+
Subcellular localization: not tested
 
 
 
 
 
 
 
Disease basic information
MONDO ID:
0007256
MONDO name: hepatocellular carcinoma
Disease details: hepatocellular carcinoma / HCC
Disease DO ID:
684, 686
Disease MeSH ID:
D006528
Disease NCIt ID:
C3099
Disease ICD11 ID:
1294035808
Disease OMIM ID:
114550
Species: Human
Species details: Homo sapiens
Tissue specimen:

HCC tissues; adjacent tissues; xenograft tumors

Cell lines:

WRL68; HepG2; SK-Hep-1; Huh7; SMMC7721

In vivo animal model:

cell line-derived xenograft

circRNA-disease information
Expression pattern:
UP
Associated gene: E-cadherin, vimentin, Snail, Ki-67
Associated microRNA: -
Biological function: Promotes HCC progression by promoting proliferation, migration and invasion, inhibiting apoptosis, and facilitating the epithelial-mesenchymal transition (EMT) process; supports tumor growth in vivo.
Molecular mechanism: Regulates EMT marker expression (E-cadherin up; vimentin and Snail down) in HCC cells and xenograft tumors; specific upstream ceRNA/protein mechanism not elucidated.
Biological pathway or process:

EMT (promotes); proliferation (promotes); migration (promotes); invasion (promotes); apoptosis (inhibits); metastasis (promotes)

Detected method:
Q
Validation methods:

RT-qPCR; Clinical Sample Validation; Transfection; CCK8; EdU Staining; TUNEL; Annexin V/PI Flow Cytometry; Transwell Assay; Western Blot; In Vivo Animal Model; IHC (Immunohistochemistry)

Clinical significance:

hsa_circ_0051908 expression was significantly correlated with tumor size, tumor differentiation, TNM stage, and lymph node metastasis; suggested as a prognostic indicator and therapeutic target for liver cancer.

Description:

hsa_circ_0051908 is up-regulated in HCC tissues and cell lines and functions as an oncogenic circRNA. Its knockdown suppresses proliferation, migration and invasion, increases apoptosis, and inhibits EMT-associated marker changes (E-cadherin up; vimentin/Snail down), reducing xenograft tumor growth.

Confidence score:

0.622

Other information
Title:

Hsa_circ_0051908 Promotes Hepatocellular Carcinoma Progression by Regulating the Epithelial-Mesenchymal Transition Process.

Journal: Analytical cellular pathology (Amsterdam)
Published: 2024
PubMed ID: 38715919
Study type:

combined biological and clinical study

Data availability: The data that supported the findings of this study are available upon reasonable request from the corresponding author.
Code availability: -